The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,757.50
Ask: 1,758.00
Change: 27.50 (1.59%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

US CORP BONDS-IG MIDDAY: Healthy flow in primary market

Wed, 13th Mar 2013 16:09

By John Balassi

March 13 (IFR) - The US high-grade primary market is seeinga healthy deal flow on Wednesday following consecutive issuancedays topping US$5bn, with a large benchmark deal helping todrive supply.

Although the credit indices have grinded to their bestlevels since the current index was rolled over in September,total returns on the Barclays Investment Grade Corporate indexhave remained negative as a result of the movement inTreasuries. Yields on the long-end of the Treasury curve havesold off almost 20bp in the past week as investors seek out morerisk.

One sector hit by extreme sensitivity to interest rates isutility operators, which tend to be debt-heavy and capitalintensive, and are also subject to regulation in terms ofraising prices to customers. Six utility companies have tappedthe new issue market this week to finance their high debt loadbefore borrowing gets too expensive.

Among the sizable offerings in the market on Wednesday isGlaxoSmithKline Capital Inc, which announceda USD benchmark SEC registered multi-tranche deal that consistsof three-year fixed and/or FRN, 10-year and 30-year seniorunsecured notes. Proceeds of the deal, led by DB, GS, JPM andUBS, are being used for general corporate purposes, includingrefinancing debt.

Initial whisper talk is that each of the tranches will bearound US$1bn, with price talk of Libor equivalents on the 3yrFRN, T+40-45bp on the 3yr fixed, T+95-100bp on the 10yr, andT+110-115bp on the 30yr.

GlaxoSmithKline capital last came to the USD market on May12, 2012 with a US$5bn three-part deal. That trade included aUS$1bn 0.75% 3yr at T+45bp, a US$2bn 1.50% 5yr at T+75bp, and aUS$2bn 2.85% 10yr at 100bp over Treasuries.

Goldcorp Inc is making the rounds with a USDbenchmark SEC registered two-part offering that consists of5-year and 10-year senior notes. The notes contain a change ofcontrol put at 101, with BAML and HSBC the active jointbooks. Proceeds are being used for debt repayment, capitalinvestment and working capital. Initial whisper talk was150-170bp on the 5yr and 187.5-200bp on the 10yr.

Skandinaviska Enskilda Banken AB is out with a USDbenchmark 144A/Reg S five-year fixed rate senior note via BAML,Barc, Citi and DB as joint books. Price guidance is T+105bp area(+/- 5bp).

Rounding out the remainder are a US$500m 144A/Reg Sfive-year from Wesfarmers Ltd, and US$250m no grow SECregistered 10-year senior note from Indiana Michigan Power Co.

At midday, the CDX indices are mostly unchanged despite anencouraging retail sales report that suggests the Americanconsumer is holding up reasonably well when factoring in highertaxes and higher energy prices.

The IG19 is currently trading 0.0625bp wider at79.50-79.9375 and the HY19 1/16 of a point lower at104.09375-104.21875. Treasuries are being moderately offered,with the 10-year yield 2.1bp higher at 2.044%.

U.S. Treasuries..........

U.S. Treasury outlook...

U.S. corporate bonds....

U.S. agencies...........

U.S. mortgage-backeds...

U.S. asset-backeds......

U.S. municipal bonds... (Reporting by John Balassi; Editing by Marc Carnegie)

More News
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.